newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Provides an Update on pheNIX Gene Therapy Trial for Adults with PKU

BEDFORD, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (NASDAQ:FIXX), a genetic medicines company, announced today that the U.S. Food and Drug Administration (FDA) has notified the company that its pheNIX gene therapy trial of HMI-1